艾米卡辛在患有血液学疾病的患者中的群体药理动力学:一项前性观察性研究
Sarah Dräger1, Sereina Livia Müller2, Severin Bausch2
1Division of Internal Medicine, University Hospital Basel, Basel, Switzerland; Department of Clinical Research, University of Basel, Basel, Switzerland.
The Journal of infection
|February 20, 2026
概括
艾米卡辛在患有发烧性中性质疏松症的血液学疾病的患者中使用的剂量显示目标达到较低. 剂量优化对于改善这些脆弱患者的阿米卡辛有效性至关重要.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
背景情况:
- 患有血液学疾病的患者有感染的高风险.
- 发烧性中性衰竭 (FN) 是这些患者常见且严重的并发症.
- 阿米卡经常用于治疗严重感染和FN.
研究的目的:
- 为了评估在患有血液学疾病的患者中,阿米卡辛的目标达到.
- 开发一个人群的药理动力学 (PK) 模型,用于阿米卡辛.
- 为了确定影响阿米卡辛暴露和疗效的因素.
主要方法:
- 在一个单一中心进行前性观察研究.
- 包括接受阿米卡辛的患有血液学疾病的成年患者.
- 在服用后1小时和8小时测量阿米卡辛的血度.
- 开发一个人群PK模型来估计个体暴露.
主要成果:
- 在19.3%的患者中观察到低目标达到 (Cmax ≥60mg/L).
- 在100%患有已识别的病原体的患者中,实现了高目标 (Cmax/MIC ≥8).
- 在PK模型中,体重和GFR被确定为重要的预测因素.
结论:
- 在为FN经验性治疗的血液性恶性瘤患者中,阿米卡辛的目标达到率低于最佳水平,特别是在具有较高MIC病原体的患者中.
- 目前的剂量策略可能需要优化以改善治疗结果.
- 对个性化剂量的进一步研究是有必要的.
相关概念视频
Estimation of k and VD of Aminoglycosides
274
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
274
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
286
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
286
Pharmacokinetics in Pediatric Patients: Drug Excretion
302
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
290
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
290
Pharmacokinetics in Pediatric Patients: Drug Distribution
354
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
354


